JRSIS Health Care Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 36.18 million compared to net income of USD 1.02 million a year ago. Basic loss per share from continuing operations was USD 0.029 compared to USD 0.001 a year ago. Diluted loss per share from continuing operations was USD 0.029 compared to USD 0.001 a year ago. Basic loss per share was USD 8.247 compared to basic earnings per share of USD 0.559 a year ago. Diluted loss per share was USD 8.247 compared to diluted earnings per share of USD 0.553 a year ago.
For the six months, net loss was USD 33.54 million compared to net income of USD 1.52 million a year ago. Basic loss per share from continuing operations was USD 0.048 compared to USD 0.018 a year ago. Diluted loss per share from continuing operations was USD 0.048 compared to USD 0.017 a year ago. Basic loss per share was USD 10.734 compared to basic earnings per share of USD 0.831 a year ago. Diluted loss per share was USD 10.734 compared to diluted earnings per share of USD 0.822 a year ago.